Clinical trial

APAF: Assessment of Cardiac Resynchronization Therapy in Patients With Permanent…

NCT00111527 · Azienda USL Reggio Emilia - IRCCS, Other · Completed

Key facts

NCT number NCT00111527
Title APAF: Assessment of Cardiac Resynchronization Therapy in Patients With Permanent Atrial Fibrillation
Official title An Assessment of the Echo-guided Optimal Cardiac Resynchronization Therapy in Patients Undergoing 'Ablate And Pace' Therapy for Permanent Atrial Fibrillation
Lead sponsor Azienda USL Reggio Emilia - IRCCS, Other
Collaborators Medtronic Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Congestive Heart Failure, Atrial Fibrillation
Intervention type Other
Interventions Optimized echo-guided CRT pacing, normal RV pacing
Enrollment 458
Start date May 1, 2005
Primary completion Aug 1, 2009
Completion Mar 1, 2010
First posted May 23, 2005
Last update posted Jun 12, 2025
Countries Italy

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies